Pindolol.
Pioglitazone.
Piracetam.
Pirbuterol, when contained in respirator solutions. (S2)
Piretanide.
Piroxicam, except when intended for the emergency treatment of acute gout attacks and when intended
for the treatment of post-traumatic conditions such as pain, swelling and inflammation, for a maximum
period of 5 days. (S2)
Pirprofen.
Potassium canrenoate.
Practolol.
Prazosin.
Primidone.
Probenecid.
Probucol.
Procaterol, when contained in respirator solutions. (S2)
Proctofene.
Propacetamol.
Propiverine.
Propranolol.
Proquazone.
Proscillaridine.
Prothionamide, when intended for oral use.
Pygeum africanum (lipido-sterolic complex extract thereof).
Pyrazinamide, when intended for oral use.
Pyrimethamine.
Pyrithioxin.
Quinapril.
Racecadotril.
Raloxifene.
Ramipril.
Ranitidine, except where administered orally for short-term symptomatic relief of heartburn and
hyperacidity, where the maximum dose is 75 milligrams, the maximum daily dose is 300 milligrams and
the maximum treatment period is two weeks. (S2)
Raubasine.
Rauwolfia alkaloids.
Repaglinide.
Reproterol, when contained in respirator solutions. (S2)
Reserpine (natural or synthetic).
Rimiterol, when contained in respirator solutions. (S2, S4)
Risedronate.
Rofecoxib.
Rosiglitazone.
Roxarzone (3-nitro-4-hydroxyphenylarsonic acid), when intended for veterinary use.
Salbutamol, when contained in respirator solutions. (S2, S4)
Salmefamol, when contained in respirator solutions. (S2, S4)
Solcoseryl; ophthalmic preparations thereof. (S0, S4)
Sotalol.
Spirapril.
Spironolactone.
Strophanthus; its glycosides and their hydrolysis products, and their derivatives, unless listed in another
Schedule.
Sulindac.
Suloctidil.
Sulphinpyrazone.
Sulthiame.
Suprofen.
Sylimarin.
Tasosartan.
Tazarotene.
Telmisartan.
Tenidap.
Tenoxicam.
Terazosin.
Terbutaline, when contained in respirator solutions. (S2)
Terizidone.
Terodiline.